Hydralazine-Isosorbide Fixed Combination 37.5/20mg Tablets

Combination tablets with hydralazine 37.5mg and isosorbide dinitrate 20mg for heart failure in African-American patients (BiDil). Classified under HTS 3004.90.92.20 due to primary hydralazine content as specified cardiovascular medicament.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90Same rate: Free

If containing nitrates as primary cardiovascular agent

Specific subheadings prioritize by active ingredient type.

3003.49Higher: 10% vs Free

If for other mixed hormone/nitrate products

Bulk mixed products before dosage form considered separately.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Justify principal active (hydralazine) for specific subheading classification

Include interaction studies for fixed-dose combo approval

Related Products under HTS 3004.90.92.20

Hydralazine Hydrochloride 25mg Tablets

These are oral tablets containing 25mg of hydralazine hydrochloride, a vasodilator used to treat hypertension and heart failure. Classified under HTS 3004.90.92.20 as a cardiovascular medicament put up in measured doses for retail sale, consisting of unmixed active ingredient in tablet form.

Apresoline 25mg Scored Tablets (Hydralazine Brand)

Brand-name Apresoline tablets with 25mg hydralazine hydrochloride, scored for dose adjustment in hypertensive emergencies. Put up in retail packs, classified in HTS 3004.90.92.20 for specific hydralazine cardiovascular medicaments.

Generic Hydralazine 50mg Film-Coated Tablets

Film-coated generic tablets delivering 50mg hydralazine with improved swallowability for daily antihypertensive regimens. HTS 3004.90.92.20 covers this as dosage-form cardiovascular product containing hydralazine salts.

Pediatric Hydralazine 1mg/ml Suspension

Compounded oral suspension at 1mg/ml hydralazine for pediatric hypertensive patients, shaken before use. Put up in measured dose bottles for retail pharmacy, under HTS 3004.90.92.20 as therapeutic cardiovascular mixed product.

Hydralazine 20mg Transdermal Patch

24-hour transdermal patch system delivering 20mg hydralazine daily for compliant hypertension management. Specifically included in HTS 3004.90.92.20 description for transdermal administration systems of cardiovascular medicaments.

Hydralazine 40mg Chewable Tablets

Chewable tablets with 40mg hydralazine, flavored for elderly patients with dysphagia in hypertension control. Dosage form for retail sale qualifies under HTS 3004.90.92.20 as measured cardiovascular medicament.